Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6065 |
Triciribine
VD-0002,Tricyclic nucleoside,NSC 154020,曲西立滨,API-2,TCN |
Akt; HIV Protease; DNA/RNA Synthesis | Cell Cycle/Checkpoint; Cytoskeletal Signaling; DNA Damage/DNA Repair; Microbiology/Virology; PI3K/Akt/mTOR signaling; Proteases/Proteasome |
Triciribine (NSC-154020) 是一种 DNA 合成抑制剂,也抑制 Akt 和 HIV-1/2,IC50分别为 130 nM 和 0.02-0.46 μM。 | |||
TNU0289 |
1,N6-Ethenoadenosine
|
||
Nucleoside Derivatives - Tricyclic nucleosides | |||
TNU1296 |
6-(β-D-5-O-(4,4’-Dimethoxytrityl)-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one
|
||
Nucleoside Derivatives - Bi-/Tricyclic nucleosides; Protected nucleosides w/NH2/OH open | |||
TNU0291 | 1,N6-Etheno-9-(b-D-xylofuranosyl)adenosine | ||
Nucleoside Derivatives - Tricyclic nucleosides; Xylo-nucleosides | |||
TNU0290 |
1,N6-Etheno-ara-adenosine
|
||
Nucleoside Derivatives - Tricyclic nucleosides; Arabino-nucleosides | |||
TNU0005 |
6-(2-O-Methyl-beta-D-ribofuranosyl)-3-(2-oxo-propyl)-6H-imidazo[1,2-c]pyrimidin-5-one
|
||
Nucleoside Derivatives - 2’-Modified nucleosides; Scaffolds and Templates;Bi-Tricyclic nucleosides |